arGEN-X's Series B - II Round

arGEN-X raised a round of funding on November 04, 2013. Investors include PMV.

arGEN-X (EBR: ARGX) (NASDAQ: ARGX) is a clinical stage human therapeutic antibody company that is rapidly developing a product pipeline using its unique suite of antibody technologies. arGEN-X is crea…

Articles about arGEN-X's Series B - II Round: